{"id":16831,"date":"2020-09-16T10:33:06","date_gmt":"2020-09-16T14:33:06","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16831"},"modified":"2020-09-16T10:33:06","modified_gmt":"2020-09-16T14:33:06","slug":"the-most-favored-nation-drug-policy","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16831","title":{"rendered":"The &#8220;most favored nation&#8221; drug policy"},"content":{"rendered":"<p>As promised, President Trump has followed through and signed executive orders that take a preliminary step toward the Administration\u2019s goal of tying domestic drug prices to the prices manufacturers charge in foreign countries.\u00a0 The \u201cmost favored nation\u201d policy is applicable to drug prices in Medicare Part B and Part D. Read article <a href=\"https:\/\/www.natlawreview.com\/article\/trump-signs-executive-orders-aimed-tying-domestic-drug-prices-to-foreign-prices\">here\u2026<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/04\/Whitehouse.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2587\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/04\/Whitehouse-300x168.jpg\" alt=\"\" width=\"300\" height=\"168\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/04\/Whitehouse-300x168.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/04\/Whitehouse.jpg 640w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>As promised, President Trump has followed through and signed executive orders that take a preliminary step toward the Administration\u2019s goal<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,20,10,6,15],"tags":[],"class_list":["post-16831","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-health-care-redesign","category-legislative-update","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16831"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16831\/revisions"}],"predecessor-version":[{"id":16832,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16831\/revisions\/16832"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}